Replies to post #198326 on Biotech Values

[DewDiligence]

EGRX—Sounds like think they have what they need, no?

Maybe. Surely, the Saudi trial could not have been any better in terms of efficacy or safety; however, the FDA may still want confirmation from a smallish US trial.